FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

385224003: poudre pour suspension injectable (forme pharmaceutique)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
22721000188113 poudre pour suspension injectable fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
2647451016 Powder for suspension for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3620910017 Powder for conventional release suspension for injection (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3620911018 Powder for conventional release suspension for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
617411000241119 poudre pour suspension injectable (forme pharmaceutique) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
poudre pour suspension injectable est un(e) (attribut) type de préparation médicamenteuse false Inferred relationship Some
poudre pour suspension injectable est un(e) (attribut) Drug powder false Inferred relationship Some
poudre pour suspension injectable est un(e) (attribut) Powder for reconstitution for drug product false Inferred relationship Some
poudre pour suspension injectable est un(e) (attribut) Injection false Inferred relationship Some
poudre pour suspension injectable est un(e) (attribut) Injection powder false Inferred relationship Some
poudre pour suspension injectable est un(e) (attribut) forme pharmaceutique pour usage parentéral (forme pharmaceutique) true Inferred relationship Some
poudre pour suspension injectable Has dose form administration method (attribute) Inject (administration method) true Inferred relationship Some
poudre pour suspension injectable Has dose form transformation (attribute) Disperse (transformation) true Inferred relationship Some
poudre pour suspension injectable Has dose form intended site (attribute) Parenteral (intended site) true Inferred relationship Some
poudre pour suspension injectable Has dose form release characteristic (attribute) Conventional release (release characteristic) true Inferred relationship Some
poudre pour suspension injectable Has basic dose form (attribute) Powder (basic dose form) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Risperidone 12.5 mg powder for suspension for injection vial a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Risperidone 50 mg powder for suspension for injection vial a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Men-C-C MENJUGATE NVD a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Penicillin G benzathine 1.2 million unit powder for suspension for injection vial a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Penicillin G benzathine 2.4 million unit powder for suspension for injection vial a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Product containing precisely triptorelin (as triptorelin pamoate) 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Lyophilized powder for conventional release suspension for injection (dose form) est un(e) (attribut) True poudre pour suspension injectable Inferred relationship Some
poudre et solvant pour solution injectable à libération prolongée est un(e) (attribut) False poudre pour suspension injectable Inferred relationship Some
Lyophilized powder for prolonged-release suspension for injection (dose form) est un(e) (attribut) False poudre pour suspension injectable Inferred relationship Some
Lyophilized powder for conventional release liposomal suspension for injection (dose form) est un(e) (attribut) False poudre pour suspension injectable Inferred relationship Some
Leuprolide acetate 7.5mg powder for injection suspension vial (product) a une forme pharmaceutique (attribut) False poudre pour suspension injectable Inferred relationship Some
Leuprolide acetate 30mg powder for injection suspension vial (product) a une forme pharmaceutique (attribut) False poudre pour suspension injectable Inferred relationship Some
Leuprolide acetate 11.25mg powder for injection suspension vial (product) a une forme pharmaceutique (attribut) False poudre pour suspension injectable Inferred relationship Some
Leuprolide acetate 22.5mg powder for injection suspension vial (product) a une forme pharmaceutique (attribut) False poudre pour suspension injectable Inferred relationship Some
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial a une forme pharmaceutique (attribut) False poudre pour suspension injectable Inferred relationship Some
Olanzapine 300mg powder for injection suspension (product) a une forme pharmaceutique (attribut) False poudre pour suspension injectable Inferred relationship Some
Olanzapine 210mg powder for injection suspension (product) a une forme pharmaceutique (attribut) False poudre pour suspension injectable Inferred relationship Some
Olanzapine 405mg powder for injection suspension (product) a une forme pharmaceutique (attribut) False poudre pour suspension injectable Inferred relationship Some
Leuprolide acetate 45mg powder for injection suspension vial (product) a une forme pharmaceutique (attribut) False poudre pour suspension injectable Inferred relationship Some
Paclitaxel 100 mg powder for suspension for injection vial a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) False poudre pour suspension injectable Inferred relationship Some
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) a une forme pharmaceutique (attribut) True poudre pour suspension injectable Inferred relationship Some

Reference Sets

Canada English language reference set (foundation metadata concept)

Description inactivation indicator reference set

GB English

US English

Back to Start